BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) ...Middle East

SHANGHAI, March 27, 2023 /PRNewswire/ -- BJ Bioscience, Inc. BJ Bioscience, a biotech company focusing on discovery and development of novel biologics for cancer immunotherapy, today announced that it entered into a clinical trial collaboration and supply agreement with MSD (Merck & Co.,...

Read More Details
Finally We wish PressBee provided you with enough information of ( BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) )

Also on site :

• LEGO Transforms Legendary Rock Band Into Custom Set
• One dead and two injured after stabbing attack at German company
• Bryan Kohberger to plead guilty in Idaho killings to avoid execution